UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

γ-secretases: from cell biology to therapeutic strategies

Lancet neurology, 2010-02, Vol.9 (2), p.215-226

2010

Volltextzugriff (PDF)

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

Neurobiology of disease, 2009-03, Vol.33 (3), p.422-428

2009

Volltextzugriff (PDF)

Defective membrane expression of the Na⁺-HCO₃⁻ cotransporter NBCe1 is associated with familial migraine

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (36), p.15963-15968

2010

Volltextzugriff (PDF)

Core auditory processing deficits in primary progressive aphasia

Brain (London, England : 1878), 2016-06, Vol.139 (Pt 6), p.1817-1829

2016

Volltextzugriff (PDF)

Corrigendum to “Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease” [Clin. Parkinsonism Related Dis. 9 (2023) 100223]

Clinical parkinsonism & related disorders, 2024, Vol.10, p.100250, Article 100250

2024

Volltextzugriff (PDF)

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

Neurobiology of aging, 2017-03, Vol.51, p.177.e9-177.e16

2017

Volltextzugriff (PDF)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease

Clinical parkinsonism & related disorders, 2023, Vol.9, p.100223, Article 100223

2023

Volltextzugriff (PDF)

Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease

PloS one, 2017-03, Vol.12 (3), p.e0173157-e0173157

2017

Volltextzugriff (PDF)

Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

Alzheimer's research & therapy, 2024-06, Vol.16 (1), p.128-18, Article 128

2024

Volltextzugriff (PDF)

Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation

NPJ Parkinson's Disease, 2021-08, Vol.7 (1), p.72-72, Article 72

2021

Volltextzugriff (PDF)

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and therapy, 2023-12, Vol.12 (6), p.1937-1958

2023

Volltextzugriff (PDF)

Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus

NPJ Parkinson's Disease, 2022-02, Vol.8 (1), p.17-17, Article 17

2022

Volltextzugriff (PDF)

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and therapy, 2023-12, Vol.12 (6), p.1959-1960

2023

Volltextzugriff (PDF)

Neurons Generated from APP/APLP1/APLP2 Triple Knockout Embryonic Stem Cells Behave Normally in Vitro and in Vivo: Lack of Evidence for a Cell Autonomous Role of the Amyloid Precursor Protein in Neuronal Differentiation

Stem cells (Dayton, Ohio), 2010-03, Vol.28 (3), p.399-406

2010

Volltextzugriff (PDF)

Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export

Acta neuropathologica, 2020-06, Vol.139 (6), p.1001-1024

2020

Volltextzugriff (PDF)

Recommendations to tackle under-recognition and under-treatment of sialorrhea in Parkinson's disease: Is it time for a paradigm shift?

Journal of the neurological sciences, 2023-12, Vol.455, p.121738, Article 121738

2023

Volltextzugriff (PDF)

Recommendations to Tackle Underrecognition and Undertreatment of Sialorrhea in Parkinson’s Disease: Is It Time for a Paradigm Shift?

Toxicon (Oxford), 2024-01, Vol.237, p.107367, Article 107367

2024

Volltextzugriff (PDF)

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease

Acta neuropathologica communications, 2021-02, Vol.9 (1), p.25-15, Article 25

2021

Volltextzugriff (PDF)

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort

Neurology, 2015-12, Vol.85 (24), p.2116

2015

Volltextzugriff (PDF)

Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign

Neurology, 2016-11, Vol.87 (19), p.e237

2016

Volltextzugriff (PDF)

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

Brain (London, England : 1878), 2016-02, Vol.139 (Pt 2), p.452-467

2016

Volltextzugriff (PDF)

Corrigendum to "Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease" Clin. Parkinsonism Related Dis. 9 (2023) 100223

Clinical parkinsonism & related disorders, 2024-01, Vol.10, p.100250

2024

Volltextzugriff (PDF)

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Parkinsonism & related disorders, 2017-12, Vol.45, p.13-20

2017

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

γ-secretases: from cell biology to therapeutic strategies

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

Defective membrane expression of the Na⁺-HCO₃⁻ cotransporter NBCe1 is associated with familial migraine

Core auditory processing deficits in primary progressive aphasia

Corrigendum to “Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease” [Clin. Parkinsonism Related Dis. 9 (2023) 100223]

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease

Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease

Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurons Generated from APP/APLP1/APLP2 Triple Knockout Embryonic Stem Cells Behave Normally in Vitro and in Vivo: Lack of Evidence for a Cell Autonomous Role of the Amyloid Precursor Protein in Neuronal Differentiation

Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export

Recommendations to tackle under-recognition and under-treatment of sialorrhea in Parkinson's disease: Is it time for a paradigm shift?

Recommendations to Tackle Underrecognition and Undertreatment of Sialorrhea in Parkinson’s Disease: Is It Time for a Paradigm Shift?

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort

Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

Corrigendum to "Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease" Clin. Parkinsonism Related Dis. 9 (2023) 100223

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability

Suchergebnisse filtern